HSBC Holdings’s Intersect ENT, Inc XENT Stock Holding History

HSBC Holdings’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-149,449	Closed	-$4.19M	–	3553
2022 Q1	$4.19M	Buy	+149,449	New	+$4.1M	0.01%	1253
2020 Q3	–	Sell	-10,384	Closed	-$140K	–	2925
2020 Q2	$140K	Buy	+10,384	New	+$121K	﹤0.01%	2463
2019 Q4	–	Sell	-15,546	Closed	-$264K	–	3248
2019 Q3	$264K	Buy	+15,546	New	+$283K	﹤0.01%	2714

HSBC Holdings's XENT Position: Q2 2022 in Review

HSBC Holdings sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 149,449 shares — an estimated $4.19M sold.

HSBC Holdings first reported a position in XENT in Q3 2019 and held it in 3 quarters. The position peaked at $4.19M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

HSBC Holdings reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
HSBC Holdings sold 149,449 Intersect ENT, Inc shares in Q2 2022, an estimated $4.19M.
HSBC Holdings first reported a position in Intersect ENT, Inc in Q3 2019 and held it in 3 quarters.
HSBC Holdings's Intersect ENT, Inc position peaked at $4.19M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on HSBC Holdings's 13F filing for Q2 2022, filed 11 Aug 2022.